PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26630041-3	2016	While on steroid treatment, the patients maintained clinical and laboratory remission, but with the initiation of mesalamine treatment, they had abdominal pain and bloody mucoid diarrhoea and/or elevation of white blood cell count, C-reactive protein level and erythrocyte sedimentation rate.	Mesalamine	114-124	C-reactive protein	Homo sapiens	232-250	
26630041-5	2016	Within 3-7 days after the mesalamine treatment had been stopped, the patients showed improvement of colitis symptoms and normalisation of white blood cell count, C-reactive protein level and erythrocyte sedimentation rate.	Mesalamine	26-36	C-reactive protein	Homo sapiens	162-180	
35584442-0	2022	C-reactive protein levels and prevalence of leukopenia in patients with inflammatory bowel disease treated with azathioprine and/or mesalazine: a real-life study.	Mesalamine	132-142	C-reactive protein	Homo sapiens	0-18	
35584442-1	2022	OBJECTIVE: To examine serum C-reactive protein levels and the prevalence of leukopenia in patients with Crohn"s disease or ulcerative colitis undergoing treatment with azathioprine and/or mesalazine.	Mesalamine	188-198	C-reactive protein	Homo sapiens	28-46	
28063246-11	2017	Besides the challenge test, elevation of CRP and positive DLST appeared to support the diagnosis of 5-ASA intolerance.	Mesalamine	100-105	C-reactive protein	Homo sapiens	41-44	
12858458-3	2003	METHODS: In an open study, mesalazine (3-4 g/day) was prescribed for 24 weeks to 20 patients (aged 18-70 yrs) with active AS, defined as the presence of at least one clinical criterion (morning stiffness > 30 min, peripheral synovitis, enthesopathy, or pain score > 2 on a visual analog scale of 10 cm) and one laboratory criterion [erythrocyte sedimentation rate (ESR) > 20 mm/h or C-reactive protein (CRP) > 20 mg/l].	Mesalamine	27-37	C-reactive protein	Homo sapiens	392-410	
12858458-3	2003	METHODS: In an open study, mesalazine (3-4 g/day) was prescribed for 24 weeks to 20 patients (aged 18-70 yrs) with active AS, defined as the presence of at least one clinical criterion (morning stiffness > 30 min, peripheral synovitis, enthesopathy, or pain score > 2 on a visual analog scale of 10 cm) and one laboratory criterion [erythrocyte sedimentation rate (ESR) > 20 mm/h or C-reactive protein (CRP) > 20 mg/l].	Mesalamine	27-37	C-reactive protein	Homo sapiens	412-415